Adenine arabinoside monophosphate in experimental vaccinia virus infections.
D000818:Animals; D001088:Arabinonucleotides / Q000627:therapeutic use*; D001921:Brain; D002675:Child, Preschool; D003586:Cytomegalovirus Infections / Q000188:drug therapy; D004195:Disease Models, Animal; D004671:Encephalitis, Arbovirus / Q000188:drug therapy; D005260:Female; D006801:Humans; D007165:Immunosuppression Therapy; D007223:Infant; D007267:Injections; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D008297:Male; D051379:Mice; D011817:Rabbits; D014615:Vaccinia / Q000188:drug therapy* / Q000276:immunology; D001084:Vidarabine Phosphate / Q000627:therapeutic use*; D014779:Virus Replication / Q000187:drug effects
D001088:Arabinonucleotides; D001084:Vidarabine Phosphate